Table 2 Patients with latent Herpes infections.
patient | sex | age | virus | Site of infection | Also treated for active infection? | Inhibition of outbreak whilst on maintenance dose? | Comments |
|---|---|---|---|---|---|---|---|
1 | M* (1) | 50 | HSVI | Orolabial | Yes Existing lesion healed. | Yes, inhibition of further outbreaks on maintenance dose >2 years. | Varied dosage, consistent inhibition. |
2 | F* (3) | 72 | HSVI prodrome | Orolabial (prodrome) and ocular conjunctiva | Yes, no progression to lesion | Yes, continued Inhibition of low grade conjunctival HSVI for three months | Notes improvement in skin condition. |
3 | F* (13) | 85 | Zoster (shingles) | Torso | Yes | Yes, inhibition for two months. | Relief from lesions requires 4 capsules per day |
4 | F* (9) | 42 | HSVII | Genital | Yes. Existing lesion healed. | Yes, inhibition of further outbreaks on maintenance dose 3 months. | Prior two weekly outbreaks of ACV resistant strain of HSVII. |
5 | F | 41 | HSVII | Genital | No(not taken during active infection) | Yes, inhibition on two capsules per day for 1 month. | Did not take during active lesion outbreak. |
6 | F | 36 | HSVII | Genital | No(not taken during active infection) | Yes, inhibition on two capsules per day for 1 month. | Did not take during active lesion outbreak. |